| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/04/2001 | EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 10/04/2001 | EP1137393A2 Deodorant cosmetic composition |
| 10/04/2001 | EP0891326B1 Novel vitamin d analogues |
| 10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 10/04/2001 | CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 10/04/2001 | CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404532A1 Method of identifying inhibitors of tie-2 |
| 10/04/2001 | CA2404528A1 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 10/04/2001 | CA2404445A1 Tricyclic protein kinase inhibitors |
| 10/04/2001 | CA2404231A1 Methods of treating diseases with activated protein c |
| 10/04/2001 | CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/04/2001 | CA2404049A1 Treatment of movement disorders |
| 10/04/2001 | CA2404012A1 External agent for the skin and whitening agent |
| 10/04/2001 | CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | CA2374911A1 G-protein coupled receptors |
| 10/04/2001 | CA2374731A1 Agent for modulating growth or generation of hair |
| 10/03/2001 | CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 10/03/2001 | CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 10/03/2001 | CN1315202A Ointment for treating psoriasis |
| 10/03/2001 | CN1315201A Ointment for treating acne |
| 10/03/2001 | CN1315193A Ointment for treating acne and its preparing process |
| 10/03/2001 | CN1315192A Ointment for treating psoriasis and its preparing process |
| 10/03/2001 | CN1315186A Medical tea for treating leukoderma and its preparing process |
| 10/03/2001 | CN1315185A Oral liquid for removing spots and its preparing process |
| 10/03/2001 | CN1315183A Tincture for treating leukoderma and its preparing process |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072016C Chinese medicine for treating seborrheic baldness |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297363 3-o-beta-d-glucopyranosyl(1-6)-beta-d-glucopyranosyl indole; isolated from calanthe discolor lindl; for promotion of hair growth and restoration |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | US6297022 Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
| 10/02/2001 | US6296878 Anti-inflammatory and anti-itching action, prevention and/or treatment of disorders of cardiovascular system, protective action against ultraviolet radiation, analgesic, promotive action on proliferation of fibroblasts, therapy of fire burn |
| 10/02/2001 | US6296856 Topically applying to the skin of such organism, a cutaneous aging-inhibitorycosmetic/pharmaceutical/dermatological composition suited to promote desquamation of mammalian skin and/or to stimulate epidermal renewal |
| 10/02/2001 | US6296851 For screening antibiotics |
| 09/27/2001 | WO2001071342A2 Identification of mast cell/basophil activation inhibitors |
| 09/27/2001 | WO2001071022A2 Lpa receptor agonists and antagonists and methods of use |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070741A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070729A1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 09/27/2001 | WO2001070716A1 A process for the preparation of epothilone analogs and intermediates |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070662A2 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 09/27/2001 | WO2001070263A1 Composition and method for the prevention and/or the treatment of allergy |
| 09/27/2001 | WO2001070255A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 09/27/2001 | WO2001070249A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | WO2001070210A2 Methods for improving size and appearance of a wound |
| 09/27/2001 | WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 09/27/2001 | WO2001070176A2 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
| 09/27/2001 | WO2001019824A3 New active marine alkaloids |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001012606B1 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 09/27/2001 | WO2000071148A3 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin |
| 09/27/2001 | WO2000061541A3 Pharmaceutical compounds |
| 09/27/2001 | US20010025154 Biodegradation |
| 09/27/2001 | US20010025107 S-lansoprazole compositions and methods |
| 09/27/2001 | US20010025057 Containing nitric oxide donar containing nitroglycerin, glycol dinitrate, isopropyl nitrate, glyceryl-1,3-dinitrate, glyceryl-1,2-dinitrate, butane-1,2,4-triol-trinitrate, erythrityl teteranitrate, pentaerithrityl tetetranitrate etc. |
| 09/27/2001 | US20010025056 A formulation for reducing/preventing glycation of proteins of skin and/or nails consists of 3,3,5,5-tetrahydroxystilbene compound or o-alky or o-acycl derivatives |
| 09/27/2001 | US20010025044 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 09/27/2001 | US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation |
| 09/27/2001 | US20010025029 Novel stromelysin inhibitors |
| 09/27/2001 | US20010024781 Substituted-2,3,4,10-tetrahydrobenzo(g)pteridin-2,4-diones; decontamination of blood, protein and blood products as well as other fluids such as juices, and surfaces of food, carcasses, bathing surfaces |
| 09/27/2001 | US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
| 09/27/2001 | DE10015006A1 Nahrungsmittel und Nahrungsergänzungsmittel mit kaltgepreßtem Traubenkernöl und/ oder Kernschrot Foods and dietary supplements with cold-pressed grape seed oil and / or crushed seeds |
| 09/27/2001 | DE10014631A1 Treating or preventing UV-induced immunosuppression, using ectoine or its derivatives, is useful in topical care or make-up cosmetic compositions for maintaining the barrier effect of the skin |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404275A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2403828A1 Inhibitors of p38 |